310. Congenital anomalies syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 11 / Drugs : 20 - (DrugBank : 10) / Drug target genes : 3 - Drug target pathways : 7
Congenital anomalies syndrome and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 310 | Congenital anomalies syndrome | - |
| 6 | Parkinson disease | 3.000 |
| 46 | Malignant rheumatoid arthritis | 3.000 |
| 96 | Crohn disease | 3.000 |
| 97 | Ulcerative colitis | 3.000 |
| 263 | Cerebrotendinous xanthomatosis | 2.000 |
| 280 | Huge arteriovenous malformation with cervicofacial or limb lesion | 1.429 |
| 94 | Primary sclerosing cholangitis | 1.404 |
| 265 | Lipodystrophy | 1.385 |
| 93 | Primary biliary cholangitis | 1.371 |
| 67 | Polycystic kidney disease | 1.368 |
| 271 | Ankylosing spondylitis | 1.366 |
| 298 | Hereditary pancreatitis | 1.358 |
| 84 | Sarcoidosis | 1.350 |
| 299 | Cystic fibrosis | 1.347 |
| 86 | Pulmonary arterial hypertension | 1.347 |
| 51 | Scleroderma | 1.345 |
| 13 | Multiple sclerosis/Neuromyelitis optica | 1.338 |